ALIVIA FAUSER: Open Payments
NPI 1073212221 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 11 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $455 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $111 |
| Amgen Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Seqirus USA Inc | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: LYBALVI, COBENFY, CAPLYTA, Fluad, ABILIFY ASIMTUFII, JARDIANCE, OTEZLA, The Cologuard Plus Collection Kit.
Industry payments across CO — which companies pay providers there.
